Hampong, Aida A.

HRN: 24-47-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2024
CEFTAZIDIME 1GM (VIAL)
01/30/2024
02/05/2024
IV
1g
Q8h
CAP-MR
Waiting Final Action 
01/30/2024
AZITHROMYCIN 500MG TABLET (TAB)
01/30/2024
02/04/2024
OD
500 Mg
OD
CAP-MR
Waiting Final Action 
02/06/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/06/2024
02/12/2024
IV
1.5g
Q6
CAP-MR
Waiting Final Action 
02/07/2024
LEVOFLOXACIN 500MG (TAB)
02/07/2024
02/13/2024
PO
500mgtab
Q24
Cap Mr
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: